5/14
07:08 am
nmra
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression [Yahoo! Finance]
Medium
Report
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression [Yahoo! Finance]
5/14
07:00 am
nmra
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
Medium
Report
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
5/7
07:16 am
nmra
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/7
07:00 am
nmra
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
5/6
07:26 am
nmra
Neumora Therapeutics to Participate in Upcoming Conferences in May [Yahoo! Finance]
Low
Report
Neumora Therapeutics to Participate in Upcoming Conferences in May [Yahoo! Finance]
5/6
07:00 am
nmra
Neumora Therapeutics to Participate in Upcoming Conferences in May
Low
Report
Neumora Therapeutics to Participate in Upcoming Conferences in May
4/24
08:41 am
nmra
We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely [Yahoo! Finance]
Medium
Report
We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely [Yahoo! Finance]
4/16
01:19 pm
nmra
Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug [Yahoo! Finance]
Low
Report
Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug [Yahoo! Finance]
3/7/2024
07:00 am
NMRA
neumora therapeutics, inc.
MISS
Report
3.3%
neumora therapeutics, inc.
5/7
04:02 pm
nmra
Form 10-Q Neumora Therapeutics, For: Mar 31
Medium
Report
Form 10-Q Neumora Therapeutics, For: Mar 31
5/7
07:15 am
nmra
Form 8-K Neumora Therapeutics, For: May 07
Medium
Report
Form 8-K Neumora Therapeutics, For: May 07
4/25
04:16 pm
nmra
Form DEFA14A Neumora Therapeutics,
Low
Report
Form DEFA14A Neumora Therapeutics,
4/25
04:06 pm
nmra
Form DEF 14A Neumora Therapeutics, For: Jun 13
Low
Report
Form DEF 14A Neumora Therapeutics, For: Jun 13
4/24
05:01 pm
nmra
Form 4 Neumora Therapeutics, For: Apr 22 Filed by: Aurora Daljit Singh
Medium
Report
Form 4 Neumora Therapeutics, For: Apr 22 Filed by: Aurora Daljit Singh
4/15
06:46 am
nmra
Form 8-K Neumora Therapeutics, For: Apr 15
Medium
Report
Form 8-K Neumora Therapeutics, For: Apr 15
3/7
04:35 pm
nmra
Form S-8 Neumora Therapeutics,
Medium
Report
Form S-8 Neumora Therapeutics,
3/7
04:08 pm
nmra
Form 10-K Neumora Therapeutics, For: Dec 31
Medium
Report
Form 10-K Neumora Therapeutics, For: Dec 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register